[PHARMA] QoQ TTM Result on 30-Jun-2022 [#2]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
19-Aug-2022
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2022
Quarter
30-Jun-2022 [#2]
Profit Trend
QoQ- -7.34%
YoY- 412.55%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
TTM Result
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
Revenue 3,428,957 3,510,677 3,359,675 4,567,669 4,983,690 4,815,015 4,737,880 -19.40%
PBT -609,092 -580,846 182,637 265,267 282,990 277,075 138,481 -
Tax -22,048 -24,204 -58,325 -100,008 -104,757 -104,870 -58,488 -47.84%
NP -631,140 -605,050 124,312 165,259 178,233 172,205 79,993 -
-
NP to SH -632,403 -607,317 122,548 163,766 176,748 172,150 80,344 -
-
Tax Rate - - 31.93% 37.70% 37.02% 37.85% 42.24% -
Total Cost 4,060,097 4,115,727 3,235,363 4,402,410 4,805,457 4,642,810 4,657,887 -8.75%
-
Net Worth -142,812 -248,894 411,327 406,087 413,947 450,411 391,428 -
Dividend
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
Div 14,409 24,889 90,356 108,678 121,759 121,748 58,895 -60.91%
Div Payout % 0.00% 0.00% 73.73% 66.36% 68.89% 70.72% 73.30% -
Equity
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
Net Worth -142,812 -248,894 411,327 406,087 413,947 450,411 391,428 -
NOSH 1,310,208 1,309,126 1,309,126 1,309,126 1,309,126 1,309,126 1,309,126 0.05%
Ratio Analysis
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
NP Margin -18.41% -17.23% 3.70% 3.62% 3.58% 3.58% 1.69% -
ROE 0.00% 0.00% 29.79% 40.33% 42.70% 38.22% 20.53% -
Per Share
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
RPS 261.71 268.00 256.47 348.69 380.45 367.74 361.91 -19.45%
EPS -48.27 -46.36 9.36 12.50 13.49 13.15 6.14 -
DPS 1.10 1.90 6.90 8.30 9.30 9.30 4.50 -60.93%
NAPS -0.109 -0.19 0.314 0.31 0.316 0.344 0.299 -
Adjusted Per Share Value based on latest NOSH - 1,309,126
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
RPS 237.92 243.59 233.11 316.93 345.79 334.09 328.74 -19.40%
EPS -43.88 -42.14 8.50 11.36 12.26 11.94 5.57 -
DPS 1.00 1.73 6.27 7.54 8.45 8.45 4.09 -60.93%
NAPS -0.0991 -0.1727 0.2854 0.2818 0.2872 0.3125 0.2716 -
Price Multiplier on Financial Quarter End Date
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
Date 31/03/23 30/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 -
Price 0.285 0.545 0.515 0.595 0.755 0.74 0.835 -
P/RPS 0.11 0.20 0.20 0.17 0.20 0.20 0.23 -38.87%
P/EPS -0.59 -1.18 5.51 4.76 5.60 5.63 13.61 -
EY -169.36 -85.07 18.17 21.01 17.87 17.77 7.35 -
DY 3.86 3.49 13.40 13.95 12.32 12.57 5.39 -19.97%
P/NAPS 0.00 0.00 1.64 1.92 2.39 2.15 2.79 -
Price Multiplier on Announcement Date
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
Date 18/05/23 27/02/23 24/11/22 19/08/22 20/05/22 17/02/22 19/11/21 -
Price 0.38 0.44 0.55 0.595 0.72 0.76 0.845 -
P/RPS 0.15 0.16 0.21 0.17 0.19 0.21 0.23 -24.81%
P/EPS -0.79 -0.95 5.88 4.76 5.34 5.78 13.77 -
EY -127.02 -105.37 17.01 21.01 18.74 17.30 7.26 -
DY 2.89 4.32 12.55 13.95 12.92 12.23 5.32 -33.44%
P/NAPS 0.00 0.00 1.75 1.92 2.28 2.21 2.83 -

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment